Parvovirus B19

Aberham, 2001, A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA, J Virol Methods, 92, 183, 10.1016/S0166-0934(00)00292-5 Abkowitz, 1997, Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection, J Infect Dis, 176, 269, 10.1086/517264 Altschuler, 1999, Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case of historical reasoning, Lancet, 354, 1026, 10.1016/S0140-6736(98)12312-7 Anderson, 1985, Experimental parvovirus infection in humans, J Infect Dis, 152, 257, 10.1093/infdis/152.2.257 Anderson, 1983, Human parvovirus. The cause of erythema infectiosum (fifth disease)?, Lancet, 1, 1378, 10.1016/S0140-6736(83)92152-9 Aractingi, 1996, Immunonistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome, Br J Dermatol, 135, 599, 10.1111/j.1365-2133.1996.tb03839.x Assy, 1997, Human parvovirus B19 associated with idiopathic thrombocytopenic purpura in a child following liver transplantation, J Hepatol, 27, 934, 10.1016/S0168-8278(97)80334-0 Aubin, 2000, Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation, Vox Sang, 78, 7, 10.1046/j.1423-0410.2000.7810007.x Azzi, 1999, The transfusion-associated transmission of parvovirus Bl9, Transf Med Rev, 13, 194, 10.1016/S0887-7963(99)80033-9 Bansal, 1993, Candidate recombinant vaccine for human B19 parvovirus, J Infect Dis, 167, 1034, 10.1093/infdis/167.5.1034 Barlow, 2000, Parvovirus B19 causing leucopenia and neutropenia in a healthy adult, J Infect, 40, 192, 10.1016/S0163-4453(00)80018-3 Bell, 1989, Human parvovirus B19 infection among hospital staff membe rs after contact with infected patients, N Engl J Med, 321, 485, 10.1056/NEJM198908243210801 Bertrand, 1985, Auto-immune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia, Lancet, 2, 382, 10.1016/S0140-6736(85)92509-7 Block, 2001, Raynaud's phenomenon, Lancet, 357, 2042, 10.1016/S0140-6736(00)05118-7 Boruchoff, 1990, Parvovirus B19 associated hemophagocytic syndrome, Arch Intern Med, 150, 897, 10.1001/archinte.1990.00390160137028 Bousquet, 2000, B19 parvovirus-induced fetal hydrops: good outcome after intrauterine blood transfusion at 18 weeks of gestation, Fetal Diagn Ther, 15, 132, 10.1159/000020991 Brennand, 2000, Human parvovirus B19 in pregnancy, Hosp Med, 61, 93, 10.12968/hosp.2000.61.2.1288 Brown, 1993, Erythrocyte P antigen cellular receptor for B19 parvovirus, Science, 262, 114, 10.1126/science.8211117 Brown, 2001, Parvovirus B19: implications for transfusion medicine. Summary of a workshop, Transfusion, 41, 130, 10.1046/j.1537-2995.2001.41010130.x Brown, 1984, Intrauterine parvovirus infection associated with hydrops fetalis, Lancet, 2, 1033, 10.1016/S0140-6736(84)91126-7 Cassinotti, 1997, Evidence for persistence of human parvovirus B19 DNA in bone marrow, J Med Virol, 53, 229, 10.1002/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A Chen, 2001, Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy, Clin Infect Dis, 32, 1361, 10.1086/319988 Chevrel, 2000, Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle, Rheumatology, 39, 1037, 10.1093/rheumatology/39.9.1037 Chua, 2000, Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8 TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae, Pediatr Infect Dis J, 19, 477, 10.1097/00006454-200005000-00019 Cohen, 1997, Chronic anemia due to parvovirus Bl 9 infection in a bone marrow transplant patient after platelet transfusion, Transfusion, 37, 947, 10.1046/j.1537-2995.1997.37997454023.x Corcoran, 2000, Impaired gamma interferon responses against parvovirus B19 by recently infected children, J Virol, 74, 9903, 10.1128/JVI.74.21.9903-9910.2000 Corman, 1992, Polyarteritis nodosa and parvovirus B19 infection, Lancet, 339, 491, 10.1016/0140-6736(92)91096-Q Cossart, 1975, Parvovirus-like particles in human sera, Lancet, 1, 72, 10.1016/S0140-6736(75)91074-0 Cotmore, 1984, Characterization and molecular cloning of a human parvovirus genome, Science, 226, 1161, 10.1126/science.6095448 Crook, 2000, Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients, Hum Pathol, 31, 161, 10.1016/S0046-8177(00)80215-4 Crowson, 2000, A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes, J Cutan Pathol, 27, 505, 10.1034/j.1600-0560.2000.027010505.x De La Rubia, 2000, Acute parvovirus B19 infection as a cause of autoimmune hemolytic anemia, Haematologica, 85, 995 Dijkmans, 1988, Human parvovirus B19 DNA in synovial fluid, Arthritis Rheum, 31, 279, 10.1002/art.1780310218 Dingli, 2000, Severe digital arterial occlusive disease and acute parvovirus B19 infection, Lancet, 356, 312, 10.1016/S0140-6736(00)02512-5 Dowell, 1995, Parvovirus infection in hospital workers: community or hospital acquisition, J Infect Dis, 172, 1076, 10.1093/infdis/172.4.1076 Doyle, 2000, Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis, J Virol Methods, 90, 143, 10.1016/S0166-0934(00)00227-5 Enders, 1998, Life-threatening pa rvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports, Clin Infect Dis, 26, 355, 10.1086/516295 Fairley, 1995, Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection, Lancet, 346, 1335, 10.1016/S0140-6736(95)92346-2 Farr, 1996, Parvovirus B19 outbreak in a rehabilitation hospital, Arch Phys Med Rehabil, 77, 208, 10.1016/S0003-9993(96)90169-0 Ferguson, 1996, Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura, Arthritis Rheum, 39, 880, 10.1002/art.1780390523 Finkel, 1994, Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?, Lancet, 343, 1255, 10.1016/S0140-6736(94)92152-0 Foto, 1993, Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence, J infect Dis, 167, 744, 10.1093/infdis/167.3.744 Franssila, 2001, Thelper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus B19, J Infect Dis, 183, 805, 10.1086/318819 Franssila, 1996, IgG subclass response to human parvovirus B19 infection, Clin Diagn Virol, 6, 41, 10.1016/0928-0197(96)00156-0 Gabriel, 1999, The role of parvovirus B19 in the pathogenesis of giant cell arteritis. A preliminary evaluation, Arthritis Rheum, 42, 1255, 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P Gautier, 1997, Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF, Hematol Cell Ther, 39, 85, 10.1007/s00282-997-0085-5 Geetha, 2000, Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature, Clin Transplant, 14, 586, 10.1034/j.1399-0012.2000.140612.x Gigler, 1999, Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins, J Virol, 73, 1974, 10.1128/JVI.73.3.1974-1979.1999 Gilbert, 2000, Parvovirus B19 infection and its significance in pregnancy, Commun Dis Intell, 24, 69 Godeau, 1995, Is still's disease associated with parvovirus B19 infection?, Lancet, 345, 59, 10.1016/S0140-6736(95)91182-0 Gratacos, 1995, The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome, J infect Dis, 171, 1360, 10.1093/infdis/171.5.1360 Haseyamak, 1997, Detection of human parvovirus B19 DNA in cerebrospinal fluid, Pediatr Infect Dis J, 16, 324, 10.1097/00006454-199703000-00013 Heegaard, 2000, Congenital anemia caused by parvovirus B19 infection, Pediatr Infect Dis J, 19, 1216, 10.1097/00006454-200012000-00024 Heegaard, 2000, Parvovirus B19 transmitted by bone marrow, Br J Haematol, 111, 659, 10.1046/j.1365-2141.2000.02407.x Heegaard, 1999, Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura, Acta Paediotr, 88, 614, 10.1111/j.1651-2227.1999.tb00009.x Hsu, 2001, Human parvovirus B19 infection in patients with systemic lupus erythematosus, Rheumotology, 40, 152, 10.1093/rheumatology/40.2.152 Jensen, 2000, An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors, Br J Obstet Gynaecol, 107, 637, 10.1111/j.1471-0528.2000.tb13306.x Jordan, 2001, Placental cellular immune response in women infected with human parvovirus B19 during pregnancy, Clin Diagn Lab Immunol, 8, 288, 10.1128/CDLI.8.2.288-292.2001 Kailasam, 2001, Congenital parvovirus B19 infection: experience of a recent epidemic, Fetal Diagn Ther, 16, 18, 10.1159/000053874 Karmochkine, 1995, Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intraveinous immunoglobulin, Am J Hematol, 50, 227, 10.1002/ajh.2830500319 Kerr, 1996, Autoantibodies following parvovirus B19 infection, J Infect, 32, 41, 10.1016/S0163-4453(96)80008-9 Kerr, 2000, Antibodies to parvovirus B19 nonstructural protein are associated with chronic but not acute arthritis following B19 infection, Rheumatology, 39, 903, 10.1093/rheumatology/39.8.903 Koduri, 1998, Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection, Am J Hematol, 58, 95, 10.1002/(SICI)1096-8652(199806)58:2<95::AID-AJH1>3.0.CO;2-V Koziol, 1992, Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff, Infect Control Hosp Epidemiol, 13, 343, 10.1086/646542 Kurtzman, 1988, Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia, Lancet, 2, 1159, 10.1016/S0140-6736(88)90233-4 Kurtzman, 1989, Immune response to B19 parvovirus and an antibody defect in persistent viral infection, J Clin Invest, 84, 1114, 10.1172/JCI114274 Kurtzman, 1988, B19 parvovirus replicates in circulating cells of acutely infected patients, Blood, 71, 1448, 10.1182/blood.V71.5.1448.1448 Lefrére, 1989, Parvovirus and idiopathic thrombocytopenic purpura, Lancet, 1, 279, 10.1016/S0140-6736(89)91290-7 Lefrére, 1985, Human parvovirus and purpura, Lancet, 2, 730, 10.1016/S0140-6736(85)92973-3 Leruez-Ville, 1994, Polyarteritis nodosa and parvovirus B19, Lancet, 344, 263, 10.1016/S0140-6736(94)93030-9 Liu, 1997, Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry, Hum Pathol, 28, 760, 10.1016/S0046-8177(97)90146-5 Lui, 2001, Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit, Transplantation, 71, 59, 10.1097/00007890-200101150-00010 Lukashov, 2001, Evolutionaiy relationship among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses, J virol, 75, 2729, 10.1128/JVI.75.6.2729-2740.2001 Lunardi, 1998, Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties, Eur J Immunol, 28, 936, 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X Lundqvist, 1999, Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders, Scand J Infect Dis, 31, 119, 10.1080/003655499750006128 Luo, 1993, A novel protein encoded by small RNAs of parvovirus B19, Virology, 195, 448, 10.1006/viro.1993.1395 Manaresi, 2001, Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins, J Med Virol, 64, 67, 10.1002/jmv.1019 McClain, 1993, Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies, Br J Haematol, 85, 57, 10.1111/j.1365-2141.1993.tb08645.x Moffat, 1998, Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells, J Virol, 72, 3018, 10.1128/JVI.72.4.3018-3028.1998 Moffatt, 1996, Acytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression, J Virol, 70, 8485, 10.1128/JVI.70.12.8485-8491.1996 Momoeda, 1994, A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity, J Virol, 68, 8443, 10.1128/JVI.68.12.8443-8446.1994 Morey, 1993, Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis, J Pathol, 169, 213, 10.1002/path.1711690207 Morinet F, Fichelson S. Parvovirus culture. Encyclopedia of Life Sciences 2001 (Nature Publishing Croup): A2582. Mortimer, 1983, A human parvovirus-like virus inhibits haematopoietic colony formation in vitro, Nature, 302, 426, 10.1038/302426a0 Murer, 2000, Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation, J Am Soc Nephrol, 11, 1132, 10.1681/ASN.V1161132 Murry, 2001, Fatal parvovirus myocarditis in a 5-year old girl, Hum Pathol, 32, 342, 10.1053/hupa.2001.22743 Naides, 1988, Human parvovirus B19 induced vesiculopustular skin eruption, Am J Med, 84, 968, 10.1016/0002-9343(88)90081-2 Nguyen, 1999, Novel human erythrovirus associated with transient aplastic anemia, J Clin Microbiol, 37, 2483, 10.1128/JCM.37.8.2483-2487.1999 Nigro, 2000, Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 case and review, Clin Infect Dis, 31, 65, 10.1086/313929 Ozawa, 1986, Replication of the B19 parvovirus in human bone marrow cell cultures, Science, 233, 883, 10.1126/science.3738514 Palmer, 1996, Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins, Clin Diagn Lab Immunol, 3, 236, 10.1128/CDLI.3.2.236-238.1996 Pattison, 1981, Parvovirus infection and hypoplastic crisis in sickle-cell anaemia, Lancet, 1, 664, 10.1016/S0140-6736(81)91579-8 Pillay, 1992, Parvovirus B19 outbreak in a children's ward, Lancet, 339, 107, 10.1016/0140-6736(92)91009-W Ray, 1997, Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers, Infect Control Hosp Epidemiol, 18, 109, 10.1086/647564 Reed Bostic, 1999, Quantitative analysis of neutralizing imune response to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay, J Infect Dis, 179, 619, 10.1086/314648 Rouger, 1987, Tissue distribution of H Lewis and P antigens shown by a panel of 18 monoclonal antibodies, Rev Fr Transf Immunohématol, 30, 699, 10.1016/S0338-4535(87)80138-1 Saint Martin, 1991, Myocardite aiguë á parvovirus devolution látale, Pédiatrie, 46, 597 Schild, 1999, Intrauterine management of fetal parvovirus B19 infection, Ultrasound Obstet Gynecol, 13, 161, 10.1046/j.1469-0705.1999.13030161.x Schowengerdt, 1997, Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection, Circulation, 96, 3549, 10.1161/01.CIR.96.10.3549 Seng, 1994, Parvovirus B19 outbreak on an adult ward, Epidemiol Infect, 113, 345, 10.1017/S0950268800051773 Seyama, 1998, Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome, J Infect Dis, 178, 318, 10.1086/515633 Shade, 1986, Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis, J Virol, 58, 921, 10.1128/JVI.58.3.921-936.1986 Shama, 2000, Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab, Blood, 96, 1184, 10.1182/blood.V96.3.1184 Shirali, 2001, Association of viral genome with graft loss in children after cardiac transplantation, N Engl J Med, 344, 1498, 10.1056/NEJM200105173442002 Skjöldebrand-Sparre, 2000, Parvovirus B19 infection: association with third-trimester intrauterine fetal death, Br J Obstet Gynaecol, 107, 476, 10.1111/j.1471-0528.2000.tb13265.x Söderlund, 1995, Epiotpe type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19, J Infect Dis, 172, 1431, 10.1093/infdis/172.6.1431 Söderlund, 1997, Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy, Lancet, 349, 1063, 10.1016/S0140-6736(96)09110-6 Sohan, 2000, Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester, Fetal Diagn Ther, 15, 234, 10.1159/000021013 Sol, 1999, Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19, J Virol, 73, 8762, 10.1128/JVI.73.10.8762-8770.1999 Srivastava, 1990, Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro, Blood, 76, 1997, 10.1182/blood.V76.10.1997.1997 Stahl, 2000, Parvovirus B19-associated mono-and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy, Clin Rheum, 19, 510, 10.1007/s100670070021 Tabak, 1999, Prolonged fever due to parvovirus induced meningitidis: a case report and review, Clin Infect Dis, 29, 446, 10.1086/520234 Takahashi, 1990, Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation, Blood, 75, 603, 10.1182/blood.V75.3.603.603 Takahashi, 1998, Human parvovirus B19 as a causative agent for rhenmatoid arthritis, Proc Nati Acad Sci USA, 95, 8227, 10.1073/pnas.95.14.8227 Tolfvenstam, 2001, Direct ex vivo measurement of CD8+ T-lymphocyte responses to human parvovirus B19, J Virol, 75, 540, 10.1128/JVI.75.1.540-543.2001 Viguier, 2001, Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin, N Engl J Med, 344, 1481, 10.1056/NEJM200105103441919 Von Poblotzki, 1996, Lymphoproliferative response after infection with human parvovirus B19, J Virol, 70, 7327, 10.1128/JVI.70.10.7327-7330.1996 Von Poblotzki, 1995, Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis, J Infect Dis, 172, 1356, 10.1093/infdis/172.5.1356 Wagner, 1995, Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection, Mayo Clin Proc, 70, 261, 10.4065/70.3.261 White, 1985, Human parvovirus arthropathy, Lancet, 1, 419, 10.1016/S0140-6736(85)91145-6 Yarali, 2000, Parvovirus Bl 9 infection reminiscent of myelodysplastic syndrome in three children with chronic hemolytic anemia, Pediatr Hematol Oncol, 17, 475, 10.1080/08880010050120836 Yoto, 1996, Human parvovirus B19 infection associated with acute hepatitis, lancet, 347, 1563, 10.1016/S0140-6736(96)91348-3 Yoto, 1994, Human parvovirus B19 infection in Kawasaki disease, Lancet, 344, 58, 10.1016/S0140-6736(94)91080-4 Young, 1984, Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro, J Clin Invest, 74, 2024, 10.1172/JCI111625